Karen Goldfinger Phd is categorized under Family Practice Doctors in Essex, CT and active since 2011.
Karen Goldfinger Phd was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Karen Goldfinger at the company’s single location by writing to 147 Westbrook Road, Essex, Connecticut CT 06426 or by phoning (860) 983-6450. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Karen Goldfinger Phd |
| Contact Person: | Karen Goldfinger |
| Address: | 147 Westbrook Road, Essex, Connecticut 06426 |
| Phone Number: | (860) 983-6450 |
| Website Address: | karengoldfinger.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Karen Goldfinger Phd was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Karen Goldfinger for inquiries that concern Karen Goldfinger Phd by calling the company number (860) 983-6450, as your correspondence is most welcome. Additionally, the physical location of the single location of Karen Goldfinger Phd can be found at the coordinates 41.337077,-72.417291 as well as the street address 147 Westbrook Road in Essex, Connecticut 06426.
For its online presence, you may visit Karen Goldfinger Phd’s website at karengoldfinger.com and engage with its social media outlets through on Twitter and on Facebook.